World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00877175
Date of registration: 06/04/2009
Prospective Registration: No
Primary sponsor: Khon Kaen University
Public title: Comparison of Instillation and Packing in Mydriasis for Premature Infants
Scientific title: Comparison of Conventional Instillation and Lower Conjunctival Fornix Packing in Mydriasis for Premature Infants
Date of first enrolment: March 2009
Target sample size: 25
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00877175
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Diagnostic  
Phase:  Phase 4
Countries of recruitment
Thailand
Contacts
Name:     Yosanan Yospaiboon, M.D.
Address: 
Telephone:
Email:
Affiliation:  Department of Ophthalmology, Faculty of Medicine, Khon Kaen University
Key inclusion & exclusion criteria

Inclusion Criteria:

- gestational age of less than 32 weeks and/or the birth weight of less than 1,500
grams

- stable clinical course

Exclusion Criteria:

- history of intraocular surgery or laser treatment

- previous eyedrop instillation that might affect the pupil size

- severe underlying disease or unstable clinical course that mydriatic drugs or the
examination could aggravate their conditions



Age minimum: 1 Month
Age maximum: 4 Months
Gender: Both
Health Condition(s) or Problem(s) studied
Preterm Infants
Intervention(s)
Drug: 1% tropicamide and 2.5% phenylephrine
Primary Outcome(s)
The primary outcome measure was the horizontal pupil diameter measured with a ruler in millimeters [Time Frame: 40 minutes after mydriatric drugs]
Secondary Outcome(s)
Secondary ID(s)
HE480729
I50221
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history